Black Diamond Therapeutics, Inc. (BDTX)
2.40
+0.07
(+3.00%)
USD |
NASDAQ |
Apr 02, 16:00
2.40
0.00 (0.00%)
After-Hours: 16:42
Black Diamond Therapeutics EPS Diluted (Quarterly) : -0.2648 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Bionano Genomics, Inc. | -0.7386 |
| IDEAYA Biosciences, Inc. | -0.9401 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -15.12M |
| Total Expenses (Quarterly) | 15.12M |
| Enterprise Value | 23.61M |
| Earnings Yield | 14.49% |
| Operating Earnings Yield | 13.25% |
| Normalized Earnings Yield | 17.92 |